Patents Represented by Attorney, Agent or Law Firm Bertram I. Rowland
  • Patent number: 4812397
    Abstract: Novel compositions and methods are provided for detecting lupus nephritis in patients suffering from SLE. Competitive or non-competitive assays may be employed, where monoconal antibodies may be used to compete with antiserum for a nucleic acid ligand or may be used for the detection of antiidiotype antibodies as diagnostic of the presence or absence of lupus nephritis.
    Type: Grant
    Filed: February 10, 1987
    Date of Patent: March 14, 1989
    Assignee: The Regents of the University of California
    Inventor: Richard H. Weisbart
  • Patent number: 4806492
    Abstract: Novel polypeptides, polynucleotide sequences, DNA constructs and compositions are provided for the preparation and use of polypeptides associated with naturally occurring polypeptides found in brains. The small molecular weight polypeptides are growth inhibitors for neoplastic cells without inhibiting normal cells. The polypeptides comprise specific regions which are highly conserved, separated by less conserved regions. The polypeptides find use in inhibiting neoplastic growth and detecting receptors for the polypeptides. Antibodies are provided in conjunction with the polypeptides, which may be used together or separately for detecting the presence of the neoplastic cell retarding polypeptides.
    Type: Grant
    Filed: August 15, 1985
    Date of Patent: February 21, 1989
    Assignee: Oncogen, Inc.
    Inventors: Mohammed Shoyab, Hans Marquardt, George J. Todaro
  • Patent number: 4801540
    Abstract: Polygalacturonase DNA sequence and its use in modulating polygalacturonase expression in plant cells. DNA constructions are provided. The transit peptide finds use with heterologous peptides.
    Type: Grant
    Filed: January 2, 1987
    Date of Patent: January 31, 1989
    Assignee: Calgene, Inc.
    Inventors: William R. Hiatt, Raymond E. Sheehy, Christine K. Shewmaker, Jean C. Kridl, Vic Knauf
  • Patent number: 4788135
    Abstract: Systems are provided for the dual purpose of cloning genes using antibodies as probes and isolating unknown proteins encoded by cloned DNA. The method employs a vector derived from phage which is used in combination with a high frequency lysogenic host. The vector is further characterized by having an inducible promoter regulating expression of a gene into which the foreign DNA may be introduced to produce a fused protein, and controlled induction of the prophage with rapid increase in copy number and high level transcription of foreign DNA. The technique is exemplified with a specific lambda phage construct in conjunction with the .beta.-galactosidase structural gene lacZ.
    Type: Grant
    Filed: October 10, 1985
    Date of Patent: November 29, 1988
    Assignee: The Board of Trustees of the Leland Stanford, Jr. University
    Inventors: Ronald W. Davis, Richard A. Young
  • Patent number: 4780117
    Abstract: Extended period cooling packs are provided by employing reaction mixtures of coated particulate matter and a liquid reactant, where the liquid reactant reacts with the particulate matter in an endothermic reaction. The coating acts to slow the rate of reaction between the reactants, so as to extend the period of cooling.
    Type: Grant
    Filed: April 14, 1987
    Date of Patent: October 25, 1988
    Inventors: Thomas P. Lahey, Steven F. Abo
  • Patent number: 4774318
    Abstract: Novel cytotoxic agents are provided as small polypeptides related to a low molecular weight peptide derived from Crotalus atrox. The compounds may be used by themselves or in combination with other reagents, such as antibodies, for inhibiting cell growth.
    Type: Grant
    Filed: December 22, 1987
    Date of Patent: September 27, 1988
    Assignee: Oncogen
    Inventors: Hans Marquardt, George J. Todaro, Daniel R. Twardzik
  • Patent number: 4766077
    Abstract: Ice nucleation bacteria are modified in vitro to confer an ice nucleation deficient phenotype. Modification is accomplished by deletion, substitution, insertion, inversion, or transversion of a DNA segment within the gene locus responsible for the INA phenotype. By limiting such mutations to the particular gene locus, the modified microorganisms are genetically stable and free from random mutations which might adversely affect their competitive fitness. The modified microorganisms are useful for prevention of frost damage to susceptible plant hosts.
    Type: Grant
    Filed: December 4, 1985
    Date of Patent: August 23, 1988
    Assignee: The Regents of the University of California
    Inventors: Cindy S. Orser, Steven Lindow, Nickolas J. Panapoulos
  • Patent number: 4762785
    Abstract: Method and compositions are provided for introducing alien DNA into a nucleic acid in vivo by providing a plasmid capable of replication in a first host, which is capable of conjugation with a second host into which the alien DNA is to be introducted. The plasmid is characterized by being capable of maintenance in said first host, being incapable of maintenance in said second host, having a region of homology with DNA present in said second host, not self-transmissable but capable of mobilization by a helper plasmid and having a marker, which may be the alien DNA, for selection in said second host. The invention finds particular application for introducing alien DNA into the Ti plasmid of Agrobacterium tumefaciens for introduction into plant cells.
    Type: Grant
    Filed: November 6, 1985
    Date of Patent: August 9, 1988
    Assignee: Calgene, Inc.
    Inventor: Luca Comai
  • Patent number: 4762780
    Abstract: DNA sequences of hCMV are obtained by restriction of the hCMV genome, the resulting fragments free of fragments cross-hybridizing with human DNA and other viruses may be used for hybridization with clinical samples suspected of containing hCMV to provide a sensitive method for detection of hCMV at low particle number.
    Type: Grant
    Filed: January 5, 1987
    Date of Patent: August 9, 1988
    Assignee: The Regents of the University of California
    Inventors: Deborah H. Spector, Stephen A. Spector
  • Patent number: 4760934
    Abstract: A beverage container lid is disclosed whereby the contents of the container may be accessed via a foldable tear strip flap defined by two score lines directed radially on the lid surface, a lift tab at the peripheral sealing skirt which mates with the rim of the container, and a multi-grooved hinge that allows for easy folding of the flap into a recess in the lid surface. Each of the two side walls of the recess has a retaining lug whereby when the user desires access to the container the flap is torn free of the peripheral sealing skirt by means of the lift tab, folded back, and inserted into the recess so as to wedge the flap below the retaining lugs which secure the flap by its opposite edges.
    Type: Grant
    Filed: May 9, 1986
    Date of Patent: August 2, 1988
    Assignee: Fiberplastics, Inc.
    Inventor: Robert R. Netsch
  • Patent number: 4758786
    Abstract: A method of analyzing selected regions of semiconductor systems to determine the uniformity of distribution of trapped charges or electric dipoles at the surface of the semiconductor or in a dielectric or insulating material associated therewith, the method including the steps of applying an adjustable bias potential to the semiconductor system to produce an electric field within the system; directing a beam of electromagnetic radiation onto a selected region of the semiconductor system in which the electric field exists to induce a photocurrent output from the system, the beam including photons of energy greater than the band gap energy of the semiconductor; adjusting the bias potential to vary the direction and/or the magnitude of the electric field; measuring the photocurrent output induced by the beam as a function of the bias potential; and determining the uniformity of distribution of trapped charges or electric dipoles in the selected region of the semiconductor system from the measured photocurrent ou
    Type: Grant
    Filed: August 6, 1986
    Date of Patent: July 19, 1988
    Assignee: Molecular Devices Corporation
    Inventor: Dean G. Hafeman
  • Patent number: 4753874
    Abstract: Mutagenic capability is determined by employing a shuttle vector having prokaryotic and eukaryotic origins, a prokaryotic marker an a gene capable of screening or selection in a prokaryote. The method involves introducing the vector into mammalian cells, exposing the cells to the candidate to be tested for mutagenicity for a time sufficient to allow lesions to occur, rescuing the vector by transforming into a prokaryotic host and screening for mutations of the gene.
    Type: Grant
    Filed: July 8, 1985
    Date of Patent: June 28, 1988
    Assignee: Board of Trustees of the Leland Stanford Junior University
    Inventor: Michele P. Calos
  • Patent number: 4752638
    Abstract: Conjugate monomers, polymers, and methods for the de novo synthesis of the polymers are provided. Conjugate organic monomers contain binding-pair members which upon polymerization become integrally associated with the resultant polymer. Specifically, antigens, antibodies, receptors, and ligands may be bound to organic monomers either directly by chemical reaction or indirectly by chemical spacer arms, and these conjugates may be polymerized or copolymerized with nonderivatized monomers to form polymers containing variable amounts of the binding-pair members. Such conjugate monomers and polymers find a wide variety of uses in binding to their binding-pair-member cognate which include selective removal of complementary binding-pair members from solution as well as in immunoassay procedures and in immunization regimes.
    Type: Grant
    Filed: June 30, 1986
    Date of Patent: June 21, 1988
    Assignee: Genetic Systems Corporation
    Inventors: Robert C. Nowinski, Allan S. Hoffman, Raymond L. Houghton, John H. Priest, Nobuo Monji
  • Patent number: 4752569
    Abstract: Detection of sialylated Lewis.sup.x antigen in sera is employed as diagnostic of the presence of cancer. Conveniently, monoclonal antibodies are provided which are shown to be useful in the diagnosis of a neoplastic condition, with a wide variety of different tumors.The hybridoma CSLEX1 was deposited at the A.T.C.C. on June 20, 1984 and given Accession No. HB8580.
    Type: Grant
    Filed: June 21, 1984
    Date of Patent: June 21, 1988
    Assignee: The Regents of the University of California
    Inventors: Paul I. Terasaki, Masaki Hirota, Kiyoyasu Fukushima, Akemi Wakisaka, Takashi Iguro
  • Patent number: 4750499
    Abstract: An FES method for partially restoring the motor function of a person having paralyzed muscles, the method comprising implanting a force sensor comprising a nerve electrode for sensing electrical signals primarily from mechanoreceptors associated with a peripheral sensory nerve that supplies glabrous skin of the person having the paralyzed muscles; producing an electrical control signal for activating a muscle stimulator in response to the electrical signals sensed by the nerve electrode; and stimulating the paralyzed muscles in accordance with the control signal.
    Type: Grant
    Filed: August 20, 1986
    Date of Patent: June 14, 1988
    Inventor: Joaquin A. Hoffer
  • Patent number: 4749647
    Abstract: Methods and compounds are disclosed for determining the presence, amount of, or association between substances of interest in samples suspected of containing same. The methods are based on the polymerization-induced separation of specifically-bound, reporter-labeled recognition reactants from free, reporter-labeled recognition reactants. The methods described are applicable to any substance for which suitable recognition reactants exist or can be made and are not limited by considerations such as chemical composition or molecular size.
    Type: Grant
    Filed: June 22, 1984
    Date of Patent: June 7, 1988
    Assignee: Genetic Systems Corporation
    Inventors: Elaine K. Thomas, Dennis E. Schwartz, John H. Priest, Robert C. Nowinski, Allan S. Hoffman
  • Patent number: 4743548
    Abstract: Microinjection techniques for plant protoplasts utilize a holding pipette for immobilizing the protoplast while an injection pipette is utilized to inject the macromolecule. In order to manipulate the protoplasts without damage, the protoplasts are cultured for from about 1 to 5 days before the injection is performed to allow for partial regeneration of the cell wall. It was found that injection through the partially regenerated cell wall could still be accomplished and particular compartments of the cell could be targeted. The methods are particularly useful for transformation of plant protoplasts with exogenous genes.
    Type: Grant
    Filed: August 1, 1985
    Date of Patent: May 10, 1988
    Assignee: Calgene, Inc.
    Inventors: Anne Crossway, Daniel Facciotti
  • Patent number: 4740470
    Abstract: Method and compositions are provided for replication and expression of exogenous genes in microorganisms. Plasmids or virus DNA are cleaved to provide linear DNA having ligatable termini, which are bound to a gene having complementary termini, to provide a biologically functional replicon with a desired phenotypical property. The replicon is inserted into a microorganism cell by transformation. Isolation of the transformants provides cells for replication and expression of the DNA molecules present in the modified plasmid. The method provides a convenient and efficient way to introduce genetic capability into microorganisms for the production of nucleic acids and proteins, such as medically or commercially useful enzymes, which may have direct usefulness, or may find expression in the production of drugs, such as hormones, antibiotics, or the like, fixation of nitrogen, fermentation, utilization of specific feedstocks, or the like.
    Type: Grant
    Filed: April 20, 1984
    Date of Patent: April 26, 1988
    Assignee: The Board of Trustees of the Leland Stanford, Jr. University
    Inventors: Stanley N. Cohen, Herbert W. Boyer
  • Patent number: 4737580
    Abstract: Novel polypeptide compositions are provided which inhibit human tumor cell growth, which may or may not stimulate autophosphorylation of pp60 src and induce the release of a 52kDal polypeptide from neoplastic cells. Individual polypeptides may be isolated from mammalian blood platelets by selected extraction and purification procedures, may be synthesized or produced by hybrid DNA technology.
    Type: Grant
    Filed: September 26, 1986
    Date of Patent: April 12, 1988
    Assignee: Oncogen
    Inventors: Daniel R. Twardzik, George J. Todaro
  • Patent number: 4737464
    Abstract: An apparatus for determining a characteristic of a signal modulating component related to an analyte of interest at an assay site by measuring light modulated by the component. A light source uniformly illuminates the assay site and a reference site. The light is directed from the sites onto a group of memory cells on the surface of a random access memory. The memory cells will decay from a logical 1 to a logical 0 due to the light over a period of time which is a function of the intensity of the light and the reference voltage of the memory cells marking the difference between a 1 and a 0. The digital state of each of the memory cells in the group is measured a predetermined exposure time. The measured states of a group of memory cells corresponding to the assay site are compared to the memory cell states for a reference group. The measured states are then analyzed to determine a characteristic of the analyte.
    Type: Grant
    Filed: September 26, 1985
    Date of Patent: April 12, 1988
    Assignee: Molecular Devices Corporation
    Inventors: Harden M. McConnell, Jonathan Briggs, John W. Parce